MedTrace Logo

The Role of Pentraxin 3 and Cathepsin B Levels in Preeclamptic Pregnancy

NCT05924061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2023-06-29

No results posted yet for this study

Summary

In this study, the investigator aim was to compare Cathepsin B and Pentraxin 3 levels measured from maternal serum of pregnant women diagnosed with preeclampsia in the second trimester, the effects of these levels on maternal/ fetal outcomes and the composite results of Cathepsin B and Pentraxin 3 levels alone or together and contribute to the literature in this area.

Conditions

  • Pre-Eclampsia
  • Cathepsin B Level
  • Pentraxin 3 Level

Interventions

OTHER

Cathepsin B and pentraxin 3 levels in preeclampsia with pregnant women

The effect of cathepsin b and pentraxin 3 levels on maternal/fetal outcomes in pregnant women diagnosed with preeclampsia

Sponsors & Collaborators

  • Sanliurfa Mehmet Akif Inan Education and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924061 on ClinicalTrials.gov